Analyst Ratings for Predictive Oncology (POAI)

POAI Rating Summary

  |   Expand Research on POAI
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/15/2024 H.C. Wainwright Swayampakula Ramakanth Downgrade Neutral
(Buy)
N/A
(N/A)
0.74
(5.95)
704.05% Details
2/1/2021 Litchfield Hills N/A New Coverage Buy
(N/A)
3.00
(N/A)
1.04
(5.95)
472.12% Details